Mohapatra Tribhuban Mohan, Singh Dharmendra Prasad, Sen Malay Ranjan, Bharti Kalpana, Sundar Shyam
Department of Microbiology, Institute of Medical Sciences, BHU, Varanasi, India.
J Infect Dev Ctries. 2010 Mar 8;4(2):114-7. doi: 10.3855/jidc.544.
This study was designed for comparative evaluation of two relatively newer recombinant hydrophilic antigens, rK9 and rK26 of Leishmania chagasi along with rK39 (a 39-aminoacid-repetitive immunodominant B-cell epitope of kinesin-related antigen from L. chagasi) and crude soluble antigen (CSA) for the serodiagnosis of Indian visceral leishmaniasis (VL) patients by quantitative ELISA.
In the present study a total of 80 subjects comprising of 55 confirmed VL cases and 25 endemic controls (EC) were subjected to ELISA using four different antigens, namely rK9, rK26, rK39 and CSA (derived from Leishmania donovani promastigotes).
Sensitivity was as follows: 78% (95%CI 63-100%) for rK9, 38% (95%CI 28-59%) for rK26, 100% for rK39, and 80% (95% CI 65-100%) for CSA. The specificity of rK9, rK26, rK39 and CSA was found to be 84% (95%CI 61-100%), 80% (95%CI 56-100%), 96% (95%CI 75-100%) and 72% (95%CI 49-100%), respectively.
rK39 was observed to be the most suitable antigen as compared to rK26 and rK9 whereas rK9 performed better than rK26. Hence rK9 antigen may either be used as an adjunct to rK39 for accurate diagnosis of VL or may be used in the absence or non-availability of rK39 antigen for the serodiagnosis.
本研究旨在通过定量酶联免疫吸附测定(ELISA),对两种相对较新的重组亲水性抗原——恰加斯利什曼原虫的rK9和rK26,以及rK39(恰加斯利什曼原虫驱动蛋白相关抗原的一个含39个氨基酸的重复性免疫显性B细胞表位)和粗可溶性抗原(CSA)进行比较评估,用于印度内脏利什曼病(VL)患者的血清学诊断。
在本研究中,总共80名受试者,包括55例确诊的VL病例和25名地方性对照(EC),使用四种不同抗原,即rK9、rK26、rK39和CSA(源自杜氏利什曼原虫前鞭毛体)进行ELISA检测。
敏感性如下:rK9为78%(95%置信区间63 - 100%),rK26为38%(95%置信区间28 - 59%),rK39为100%,CSA为80%(95%置信区间65 - 100%)。rK9、rK26、rK39和CSA的特异性分别为84%(95%置信区间61 - 100%)、80%(95%置信区间56 - 100%)、96%(95%置信区间75 - 100%)和72%(95%置信区间49 - 100%)。
与rK26和rK9相比,rK39被认为是最合适的抗原,而rK9的表现优于rK26。因此,rK9抗原既可以作为rK39的辅助手段用于VL的准确诊断,也可以在没有rK39抗原或无法获得rK39抗原时用于血清学诊断。